Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab

NCT03369574 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT03369574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study of Chronic Rhinosinusitis Symptoms in Asthma Patients Undergoing Treatment With Reslizumab
Lead sponsor
University of Rochester
Phase
Observational
Overall status
Withdrawn
Start date
November 14, 2017
Completion date
October 19, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, chronic rhinosinusitis (diagnosis), nasal polyps